NovaBay Pharmaceuticals (NBY)
(Delayed Data from AMEX)
$0.08 USD
-0.01 (-9.97%)
Updated May 10, 2024 04:00 PM ET
After-Market: $0.08 0.00 (-0.50%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth A Momentum B VGM
Brokerage Reports
0 items in cart
NovaBay Pharmaceuticals, Inc. [NBY]
Reports for Purchase
Showing records 41 - 60 ( 109 total )
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
2017 2Q Financial Results Reported; 2017 $19M Revenue Guidance Affirmed; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
2017 2Q Financial Results Reported; 2017 $19M Revenue Guidance Affirmed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
2Q17 Recap - Pricing Hurt Quarter, but Guidance Maintained
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NovaBay Pharmaceuticals, Inc.
Industry: Medical - Drugs
Avenova Tracker - Week Ending 7/7/2017 Holiday Noise.
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S